Investors Bet Big on Cancer Drug Infant Duality Biologics and Its Rockstar Founder
Company has raised $120 million in 18 months from A-list investors including Eli Lilly and domestic heavyweight WuXi Biologics Key takeaways Duality Biologics’ new $90 million funding just 18 months…
RELATED ARTICLES
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK -
Akeso marks profit milestone with swift rights issue
9926.HK
- Sichuan Biokin chases Hong Kong listing after BSM drug deal
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
